Search

everythinglearnresearchcommunity

for

Search:↓

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Mirtazapine may cause hair loss and change hair color, but stopping the drug can reverse these effects.

Quetiapine may cause hair loss, a side effect not widely recognized before.

Alopecia areata treatments often cause headaches and infections, highlighting the need for safer options.

Chemotherapy reduces splenic melanin in mice.

Progesterone reduces anxiety without needing progesterone receptors.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Providing housing and case management reduces hospital visits for chronically ill homeless adults.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Blocking interferon-gamma might help treat various autoimmune diseases.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

MVP treatment is effective and safe for recurrent breast cancer.

Stopping aripiprazole can reverse its side effect of hair loss.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Aftimoon (Cuscuta reflexa) has various health benefits, including anti-inflammatory and anticonvulsant effects.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Enteral nutrition's role in maintaining Crohn's disease remission is unclear and needs more research.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.